Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

Share Price is delayed by 15 minutes
Get Live Data
134.00    0.00 (0.00%)
Bid:
133.00
Ask:
135.00
Spread: 2.00 (1.504%)
Market Cap: £126.23m
TRU Live PriceLast checked at - London Stock Exchange

Intraday Trufin Plc Share Chart

Share Buyback Programme

22 May 2025 07:00

RNS Number : 7591J
TruFin PLC
22 May 2025
 

 

LEI: 213800C2QPZFECSRZ964

22 May 2025

 

 

TruFin plc

 ("TruFin" or the "Company" or together with its subsidiaries "TruFin Group" or the "Group")

 

 

Share Buyback Programme

 

 

TruFin (AIM: TRU) is pleased to announce the commencement of a share buyback programme ("Share Buyback Programme") to purchase ordinary shares of £0.91 each in the capital of the Company ("Ordinary Shares") up to a maximum aggregate consideration of £4 million (the "Maximum Amount").

 

As announced in the Group's trading update on 20 May 2025, the Share Buyback Programme is being initiated due to the Board's belief that the Company's shares trade at a discount to an internally calculated intrinsic value, in order to further enhance shareholder returns and to reduce the Company's share capital. Any Ordinary Shares acquired as a result of the Share Buyback Programme will be cancelled.

 

Details of the Buyback

 

The Group has entered into an agreement with its broker Panmure Liberum Limited ("Panmure Liberum") to carry out purchases of its Ordinary Shares under the Share Buyback Programme on its behalf. Panmure Liberum will manage the purchases on a discretionary basis, purchasing Ordinary Shares on the London Stock Exchange within certain pre-set parameters over the Share Buyback Programme up to the Maximum Amount.

 

Prior to the Company's next annual general meeting to be held on 12 June 2025 (the "2025 AGM"), the Share Buyback will take place within the limitations of the authority granted to the Board of TruFin at its annual general meeting ("General Authority"), held on 5 June 2024 (the "2024 AGM"), pursuant to which the maximum number of Ordinary Shares which may be bought back is 10,598,688, representing 10 per cent. of the Company's issued share capital. Thereafter, provided the relevant resolution is approved at the 2025 AGM, this limit will increase to 15,898,003, representing 15 per cent. of the Company's issue share capital.

 

In line with the authority given at the 2024 AGM, and the authority proposed at the 2025 AGM, the maximum price (exclusive of expenses) which may be paid for an Ordinary Share shall not be more than an amount equal to 105% of the average middle market quotations for an Ordinary Share, as derived from London Stock Exchange Daily Official List, for the five business days immediately preceding the day on which the Ordinary Share is contracted to be purchased.

 

Shareholders should be aware that the Share Buyback Programme may on any given trading day represent a significant portion of the daily traded volume in the Group's Ordinary Shares on the London Stock Exchange, and may exceed 25% (but not 50%) of the average daily traded volume on the London Stock Exchange during the 20 trading days preceding the date of purchase of such Ordinary Shares (the "Volume Limit"). Accordingly, the Group may not benefit from the exemption contained in Article 5(1) of MAR. The Volume Limit may be exceeded should Panmure Liberum consider, at its discretion, that an opportunity has arisen to acquire a significant number of shares in one trade. In such circumstances, an announcement of the purchase will be made as soon as possible following such trade taking place.

 

The Group has authorised the Share Buyback Programme to commence from today and will continue until the earlier of: (i) the date on which the Maximum Amount payable by the Company has been reached, or (ii) 31 August 2025, conditional on the share buyback authority being renewed at the Company's 2025 AGM.

 

Any market purchase of Ordinary Shares pursuant to the Share Buyback Programme will be announced no later than 7:30am (UK time) on the business day following the day on which the purchase occurred.

 

 

For further information, please contact:

 

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

 

0203 743 134007779 229508

 

Panmure Liberum Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

 

0203 100 2000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEWSIEEISEFI
Date   Source Headline
19th Oct 20217:00 amRNSResignation of Director
14th Oct 20213:03 pmRNSHolding(s) in Company
12th Oct 20217:00 amRNSHolding(s) in Company
12th Oct 20217:00 amRNSHolding(s) in Company
12th Oct 20217:00 amRNSHolding(s) in Company
11th Oct 202111:24 amRNSHolding(s) in Company
7th Oct 20215:13 pmRNSResult of secondary placing in TruFin plc
7th Oct 20212:40 pmRNSProposed Secondary Placing in TruFin plc
29th Sep 202111:05 amRNSSecond Price Monitoring Extn
29th Sep 202111:00 amRNSPrice Monitoring Extension
29th Sep 20217:00 amRNSInterim Results
10th Jun 20217:00 amRNSStatement re Satago
8th Jun 202111:26 amRNSHolding(s) in Company
8th Jun 202110:14 amRNSResult of AGM
10th May 20217:00 amRNSNotice of Annual General Meeting Posting
19th Apr 20217:00 amRNSFinal Results For The Year Ended 31 December 2020
23rd Feb 20212:52 pmRNSVesting of JSOP Founder Awards
11th Feb 20217:00 amRNSHolding(s) in Company
10th Feb 20217:00 amRNSHolding(s) in Company
9th Feb 20213:37 pmRNSHolding(s) in Company
9th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202111:04 amRNSHolding(s) in Company
8th Feb 20217:00 amRNSHolding(s) in Company
5th Feb 20215:32 pmRNSResult of secondary placing in TruFin plc
5th Feb 20212:47 pmRNSProposed secondary placing in TruFin plc
19th Jan 20217:00 amRNSTrading & Company Update
22nd Dec 20207:00 amRNSHolding(s) in Company
11th Dec 20207:00 amRNSStatement re Satago
9th Dec 20207:00 amRNSDF Capital Loan Repayment
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:01 pmRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSDF Capital Loan Repayment
12th Oct 20207:00 amRNSStatement re Company Event
25th Sep 20207:00 amRNSHalf-year Report
23rd Sep 20201:16 pmRNSHolding(s) in Company
14th Aug 202011:55 amRNSDF Capital Loan Amendment
6th Aug 20207:00 amRNSChange of Adviser
26th Jun 202012:35 pmRNSResult of AGM
9th Jun 20207:00 amRNSNotice of Annual General Meeting Posting
1st Jun 20202:52 pmRNS2020 Annual General Meeting and Board Changes
15th May 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
13th May 202011:05 amRNSHolding(s) in Company
13th May 20207:00 amRNSHolding(s) in Company
11th May 202010:43 amRNSHolding(s) in Company
29th Apr 202010:33 amRNSAppointment of a Non-Executive Director
24th Mar 20207:00 amRNSPre-Close Trading Update
20th Mar 20204:00 pmRNSStatement Regarding Satago
21st Feb 20207:00 amRNSVesting of JSOP Founder Awards
24th Dec 20197:00 amRNSResult of Tender Offer
23rd Dec 201910:26 amRNSGeneral Meeting Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.